Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
about
9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotectionPersonalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfallsMorphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction.Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk managementPharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives.Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.New directions for pharmacotherapy in the treatment of acute coronary syndrome.Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.Why we need intravenous antiplatelet agents.Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.Pharmacokinetics and pharmacodynamics of ticagrelor in the treatment of cardiac ischemia.Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach.Morphine in acute heart failure.Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients.Polish trials influencing 2017 European Society of Cardiology guidelines on acute myocardial infarction in patients presenting with ST-segment elevation.In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine.Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study.Ticagrelor - toward more efficient platelet inhibition and beyond.Effect and Safety of Morphine Use in Acute Anterior ST-Segment Elevation Myocardial Infarction.[Acute myocardial infarction in patients with ST-segment elevation myocardial infarction : ESC guidelines 2017].Practical considerations for cangrelor use in patients with acute coronary syndromes.Intra-coronary morphine versus placebo in the treatment of acute ST-segment elevation myocardial infarction: the MIAMI randomized controlled trialMetabolism of ticagrelor in patients with acute coronary syndromes
P2860
Q26750797-84EFB9A4-B03C-4E0B-9E25-580EAB7084ABQ26775125-5D04F355-7688-4679-820B-B6589D1856EDQ36247929-CDC3CD27-E939-4D38-8C5C-820DF3C0488BQ36392325-42026C8D-3E50-42E7-9448-99B5BCD332DDQ37724614-C3B974F3-C8E3-4A7C-BC6B-BC931FEC80B2Q38378564-5D750B94-433F-4CD4-93E1-60FBB571E528Q38381383-6050289D-ECC6-4797-A769-20603B47B47DQ38817144-8930DBE9-8284-4DBC-B829-59791F0EEBA0Q38818086-3881BCE3-5D25-45F9-9785-D505ACCC494AQ38851769-F453C3AF-2110-4C6F-9752-0A234320B5D8Q38958862-C8112095-6362-45AD-BBF4-B5F294C1AD86Q38974884-0D16A9BD-B377-41C8-81DB-38D6D2761469Q40717885-D76178B5-9DEE-4D40-B768-034C3E02B628Q42342027-4020556D-6049-4C59-93B1-FB76E0CF77E5Q42375730-6F6272FA-402B-41E6-A1FE-9C2D0E866BA3Q42700913-DF799F04-9B9C-456E-BB73-E17FF603B805Q47133185-C6879973-C6FD-458E-A66E-06A0A6650EAAQ48252169-B3CF6CF6-97A0-4F4B-A463-DC3F22A62876Q48344587-B83B6040-A96F-44EA-BCEF-A655024F2E1EQ48628910-9B5812D5-B06C-461F-90CF-5AB538433FEAQ49337303-0FF0F8AC-57D4-4F6C-8C88-42E02AD10724Q50027852-20175A13-0A0F-465D-B8ED-DCC085704A44Q50101365-BE55C578-46E6-4C5E-9A43-397A8E50073CQ53250732-AD332016-98BF-48BA-9DF5-1F065AFB9AFDQ57809365-8365418B-4871-4396-9871-9F5D7E6EF06BQ58799733-B4F7976E-90BD-4A1E-9807-59F7BF9C21DE
P2860
Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@ast
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@en
type
label
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@ast
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@en
prefLabel
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@ast
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@en
P2093
P2860
P50
P356
P1476
Morphine delays and attenuates ...... o-controlled IMPRESSION trial.
@en
P2093
Bernd Jilma
Danuta Rość
Eliano Pio Navarese
Julia Maria Kubica
Katarzyna Buszko
Katarzyna Stankowska
Marek Koziński
Małgorzata Ostrowska
Michał Piotr Marszałł
Wiktor Dariusz Sroka
P2860
P304
P356
10.1093/EURHEARTJ/EHV547
P577
2015-10-21T00:00:00Z